Alterity initiates Phase II multiple system atrophy therapy trial
The double-blind, placebo-controlled, randomised trial will analyse ATH434 in subjects with early-stage MSA.
New Zealand
Latest in
New Zealand
Pardes reports interim data from Phase I trial of oral Covid-19 antiviral
Findings showed that PBI-0451 was well tolerated with mild treatment-emergent adverse events.
Sciwind commences dosing in Phase IIb obesity drug trial
The trial will be carried out in Australia and New Zealand, and will enrol nearly 200 patients with obesity.
Valneva commences Phase III trial of Covid-19 vaccine in New Zealand
The VLA2001-304 trial intends to obtain safety and immunogenicity data in the elderly and aid in variant-bridging.
Setback of Seres’s late-stage candidate challenges microbiome space – register for free webinar
Join GlobalData on 10 August 2021 at 4pm BST for a free webinar giving an overview of the microbiome-targeting treatment…
By
Researchers conduct study to increase trial participation in New Zealand
A national team of expert clinicians and health researchers in New Zealand are leading a new study to make more…
New Zealand researchers work on three Covid-19 trials
Researchers at Medical Research Institute of New Zealand have announced REMAP-CAP, MRINZ and ASCOT clinical trials to study potential treatments…
Covid-19 delays enrolment for resTORbio’s Parkinson’s trial
resTORbio has put enrolment for the fifth cohort of RTB101’s Phase Ib/IIa Parkinson’s disease (PD) trial on hold amid the…